DNA & RNA Banking Services Market Share, Size, Trends, Industry Analysis Report, By Service (Transportation, Processing, Storage, Quality Control, Data Storage, Others); By Specimen (Blood, Buccal Swabs & Hair Follicles, Others); By Application; By End-Use, By Regions; Segment Forecast, 2021 - 2028

报告摘要

全球DNA和RNA银行业务市场于2020年的价值为62.1亿美元，预计预测期内复合年增长率为5.3％。生物银行服务被确定为加速药物发现以开发新的治疗方法的关键领域之一，特别是在肿瘤学适用。

了解有关此报告的更多信息：request for sample pages

这种多学科方法适用于治疗监测，疾病预测，预防措施，药物发现和优化。因此，DNA和RNA银行服务市场预计会在预测期内见证市场增长。

因此,全球癌症病例的增加是滑稽可笑的ipated to drive the DNA & RNA banking services industry growth. Cancer is the second largest death cause in the U.S. alone, after heart diseases. As per the estimates of the American Cancer Society, there are more than 1.8 million new cases of cancer, by 2020, in the U.S. alone. It is being estimated that around 606,520 people in the U.S., die after contracting cancer. High cancer prevalence, resulted in demand for cancer research, which further propels DNA & RNA banking services demand.

DNA＆RNA银行服务市场报告范围

The market is primarily segmented on the basis of service, specimen, application, end-use, and geographic region.

通过服务	通过标本	通过申请	By End-Use	按地区
Transportation Processing Storage 质量控制 数据存储 Others	血液 口腔拭子和发毛卵泡 Others	疗法 Drug Discovery & Clinical Research Clinical Diagnostics Other Applications	Academic Research 药物和生物技术 Companies 医院和诊断中心 Others	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

Insight by Service

2020年，DNA和RNA银行服务市场的存储设备段占收入份额最大的收入份额。这是高质量的市场份额，归因于高质量的研究目的的生物学。可靠的长期稳定和储存解决方案对BioBanks的开发至关重要。生物样品需要储存在高达-496ocelsius的温度控制的储存设施中。

这些系统的简单可用性，例如由SPT Labtech制造的化合物和arktic系统，可以很容易地配置为具有-80ocelsius的温度。该平台非常适用于2D条形码管，以满足微量升的存储体积至1.2毫升。因此，环境存储设施的存在积极影响市场部门的需求。

The quality control market segment is expected to witness the highest growth rate over the study period. The presence of several guidelines to improve the quality of specimens. Bio-specimen Reporting for Improved Study Quality strengthens the publication related to the bio-specimen research. France on the other hand has already introduced specific region-specific guidelines to regulate DNA & RNA banking services.

Insight by Specimen

In 2020, the blood market segment of DNA & RNA banking services market held the largest share. It is the most used sample type by clinicians for routine lab tests. It is the most common non-invasive biomarker specimen type for cancer studies. Moreover, blood sample collection time does not interfere with the count of DNA and RNA.

血液收集是前线医疗工人的一类认证的主要技能。它需要特殊的收集管和静脉穿刺。额外的标本集合将其存放在BioBanks中并未担任患者，使血液收集复杂化。此外，血清和血浆主要是优选的用于样品收集的无细胞DNA，蛋白质或激素。

The buccal swaps market segment is projected to witness a lucrative growth rate over the study period. The collection of buccal swabs samples is one of the fastest methods, which does not require any medically trained professional. Mostly, hair samples are used in forensic studies. Moreover, the rise in COVID cases has increased exponentially, owing to the increase in market demand for swabbing testing.

Insight by End Use

In 2020, the academic market segment held the largest revenue share. A huge pool of researchers in research institutions involved in any kind of research is largely responsible for such growth. A paradigm shift towards biomarker therapy, personalized medicine, and tailored therapies offered by biomarkers also attributed to the growth of the segment and market for DNA & RNA banking services.

Academic institutions are involved to understand differences between several treatment types and their response type. Colorado Center for Personalized Medicine (CCPM) is one such type of institute which is involved in personalized medicine. This biobank collects and stores different biological samples.

Hospitals market segments of DNA & RNA banking services industry are projected to witness a lucrative growth rate over the assessment period. This is primarily due to strong relations and collaborations with associations, for instance, more than 80,000 have already consented to transfer rights of their biological sample to Partners Biobank to the Spaulding Rehabilitation Hospital, Massachusetts General Hospital, and McLean Hospital.

Geographic Overview

2020年，北美市场的DNA和RNA银行服务占全球市场的30％以上。这一高度归功于存在广泛的BioBanks网络以及其中在该国采取的努力。加拿大肿瘤储存库网络是加拿大政府资助的非营利生物银行网络。收集和储存血液，组织和唾液样本的癌症患者，以进一步研究目的。

美国政府还支持该国全面的BioBanks网络。合作人体组织网络是国家癌症研究所支持和资助的一个组织。它通常为来自癌症患者的现有标本提供各种研究主题的现有标本提供血液和组织微阵列。

亚太市场的DNA和RNA的银行服务is projected to witness the highest growth rate over the study period. Demand in the region is primarily due to awareness among stakeholders about the concept of bio-banking through conferences and industry consortiums. For instance, in September 2020, Japan hosted the International Conference on Advanced Bio-banking and Biotechnology to spread awareness in Asian countries.

竞争洞察力

在DNA和RNA银行服务业的突出市场参与者是Easydna，23andme，Inc。，Goodcell，Proteogenex，LGC Biosearch Technologies，DNA Genotek Inc.，US Biolab Corporation，Inc。，Thermo Fisher Scientific，Inc。解码遗传学，无限生物糖精，布鲁克斯生命科学和预防性学。

The companies operating in the DNA & RNA banking services industry have adopted several innovative techniques for transportation, processing, storage, and quality control. Furthermore, the companies are using strategies to gain edge over their competitors increasing the competition in the DNA & RNA banking services industry.